Spotlight Innovation Inc. (OTCQB: STLT) identifies, acquires and incubates companies that have unique intellectual property (IP) in the medical sector. The Company has relationships with the nation’s leading academic and institutional IP developers, and locates promising IP technologies with potential for market share capture. With strong support, development, resources and strategic planning expertise, we believe we can develop IP that will have a positive effect on healthcare. We partner with proven sector leaders on commercialization once technologies are fully developed.

Spotlight Innovation Inc. subsidiary company Celtic Biotech Iowa, Inc. is developing novel, clinical trial-phase products for the treatment of cancers and pain in humans. Derived from naturally specialized receptor-binding proteins, these products have the potential to reduce treatment costs, increase survivability, and improve the quality of life for cancer patients. Additional information available at www.celticbiotech.com.

Spotlight Innovation Inc. subsidiary Memcine Pharmaceuticals, Inc. is an early-stage biotech company focused on enhancing vaccine efficacy to improve human and animal health globally. Memcine’s Immunoplex™ technology platform uses the body’s naturally occurring targeting system to deliver vaccine components. Additional information available at www.memcine.com.

Spotlight Innovation Inc. is based in West Des Moines, IA. Additional information available at www.spotlightinnovation.com.